Susquehanna Fundamental Investments, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.33 - $8.76 $91,028 - $239,463	-27,336 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.27 - $4.64 $101,474 - $143,988	-31,032 Reduced 53.17%	27,336 $90,000
Q3 2020 Nov 16, 2020	BUY	$3.23 - $4.3 $92,920 - $123,702	28,768 Added 97.19%	58,368 $193,000
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $97,976 - $193,584	29,600 New	29,600 $100,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.